Products from BPS Bioscience require a minimum order value above 400€
Application: Expression of human B2M HLA-B*07:02 in cells of interest.Generate B2M HLA-B*07:02 expressing cell pools or stable cell lines by puromycin selection.
Background: Human Leukocyte Antigen-B (HLA-B) is an MHC-I (major histocompatibility complex) heavy chain receptor, composed of HLA-B and β2-microglobulin (B2M). There are over 200 genes encoding HLA variants and this variability plays a critical role in adaptive immunity. HLA-B has been linked to autoimmune disorders and drug reactions. B2M HLA-B*07:02 has been linked to an improved HIV disease progression but contribute to severe adverse drug reaction to TMP-SMX (trimethoprimsulfamethoxazole) associated respiratory failure. The understanding of the association between HLA alleles and diseases will allow a refinement of therapeutic strategies.
Description: B2M HLA-B*07:02 Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles ready to transduce most mammalian cells, including primary and non-dividing cells. These viruses result in the expression of B2M (beta-2 microglobulin) HLA (human leukocyte antigen)-B*07:02 driven by an EF1a promoter. The lentiviruses also contain a puromycin selection marker (Figure 1).Figure 1. Schematic of the lenti-vector used to generate B2M HLA-B*07:02 Lentivirus.
Formulation: The lentivirus particles were produced in HEK293T cells. They are supplied in medium containing 90% DMEM + 10% FBS. Virus particles can be packaged in custom formulations and produced at higher titers by special request, for an additional fee.
Storage Stability: Lentiviruses are shipped with dry ice. For long-term storage, it is recommended to store the lentiviruses at -80°C for up to 12 months from date of receipt. Avoid repeated freeze-thaw cycles. Titers can drop significantly with each freeze-thaw cycle.
Supplied As: Two vials (500 µl x 2) of lentivirus at a titer ≥107 TU/ml. The titer will vary with each lot; the exact value is provided with each shipment.
Target: B2M, HLA
Uniprot: P61769, P04439
Warnings: BiosafetyThe lentiviruses are produced with a SIN (self-inactivation) lentivector which ensures self-inactivation of the lentiviral construct after transduction and after integration into the genomic DNA of the target cells. of the HIV genes (gag, pol, rev) will be expressed in the transduced cells, as they are expressed from packaging plasmids lacking the packing signal and are not present in the lentivirus particle. Although the pseudotyped lentiviruses are replication-incompetent, they require the use of a Biosafety Level 2 facility. BPS Bioscience recommends following all local federal, state, and institutional regulations and using all appropriate safety precautions.Avoid freeze/thaw cycles.
Biosafety Level: BSL-2
SIN Vector?: Yes
References: Kloverpris H., et al., 2014 AIDS Res Hum Retroviruses 30 (5):468-475.Goldman J., et al., 2022 Pharmacogenomics J. 22(2): 124-129.
English
Deutsch
